ISTH 2020 Congress
Platelet Disorders and von Willebrand Disease » Antiplatelet Therapy
Theme Navigation
- ISTH 2020 Congress
- Platelet Disorders and von Willebrand Disease
- Antiplatelet Therapy
- Platelet Disorders and von Willebrand Disease
-
Abstract Number: PB1408
Assessment of the Hemostatic System by Total Thrombus-formation Analysis System (T-TAS) in Patients with Chronic Coronary Syndromes
-
Abstract Number: PB1404
Circulating Myeloid-related Protein (MRP)-8/14 May Contribute to Suboptimal Response to Low Dose Aspirin in Patients with Type 2 Diabetes mellitus
-
Abstract Number: PB1395
Comparison of Platelet Function Testing in Patients Undergoing Neuroradiological Flow Diversion Stents
-
Abstract Number: PB1406
Correlation of VASP Phosphorylation Assay with Light Transmission Aggregometry for Patients Treated with Clopidogrel or Ticagrelor
-
Abstract Number: PB1390
Desmopressin for Reversal of Antiplatelet Drugs in Stroke due to Haemorrhage (DASH): Interim Report on Recruitment from a Phase II Double Blind Randomised Controlled Trial
-
Abstract Number: PB1393
Detection of Clopidogrel Resistance: Comparison of Light Transmission Aggregometry and INNOVANCE® PFA P2Y Cartridge and Correlation with CYP2C19 Variants
-
Abstract Number: PB1402
Discontinuation of Chronic Low Dose Acetylsalicylic Acid Therapy Upon Intensive Care Medicine Department Admission Appears to Increase Mortality
-
Abstract Number: PB1392
Efficacy of Antiplatelet Therapy in Patients with Acute Ischemic Stroke Treated with Acetylsalicylic Acid
-
Abstract Number: PB1398
Evaluation of Dual Antiplatelet Therapy Combining Aspirin and Clopidogrel for Intracranial Stenting Procedures: A Retrospective Single Center Study
-
Abstract Number: PB1403
Evaluation of Platelet Reactivity in Pediatric Patient on Dual Antiplatelet Therapy after Stent Implantation of Ductus Arteriosus: A Case Report
-
Abstract Number: PB1387
Long-term Variation of Platelet Reactivity in High-Risk Patients on Antiplatelet Therapy after Percutaneous Coronary Intervention
-
Abstract Number: PB1391
Lysine-Containing Peptides as Promising Antiplatelet Drugs
-
Abstract Number: PB1384
Platelet Function Assay PFA-200 for Monitoring of Antiplatelet Drug Effect
-
Abstract Number: PB1394
Potent platelet inhibition results in improved long-term clinical outcome independent from clinical variables
-
Abstract Number: PB1388
Synthesis of Antiplatelet Ortho-Carbonyl Hydroquinones: A Spiro Derivative is Selective against Collagen-Stimulated Platelets
-
Abstract Number: PB1389
The Effect of Aspirin in Tumor Growth of Obese Mice Involving Inhibition of Metabolism
-
Abstract Number: PB1401
The Effect of Plasma Fibrinogen Level on Predictive Value of VerifyNow P2Y12 Assay Results in Patients Undergoing Percutaneous Coronary Interventions
-
Abstract Number: PB1397
Ticagrelor Mechanism of Action on Gram-Positive Bacteria